1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cardiovascular conditions
  5. Acute coronary syndromes

Ticagrelor for the treatment of acute coronary syndromes

Technology appraisal guidance [TA236] Published date: 26 October 2011

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History
  • Overview
  • 1 Guidance
  • 2 The technology
  • 3 The manufacturer's submission
  • 4 Consideration of the evidence
  • 5 Implementation
  • 6 Recommendations for further research
  • 7 Related NICE guidance
  • 8 Review of guidance
  • Appendix A: Appraisal Committee members and NICE project team
  • Appendix B: Sources of evidence considered by the Committee
  • Changes after publication
  • About this guidance
  • Share
    • Share
    • Linked In
    • Twitter
    • Facebook
    • Email
    • More...
  • Download

Guidance

  • Next

7 Related NICE guidance

7 Related NICE guidance

  • Bivalirudin for the treatment of ST-segment elevation myocardial infarction.NICE technology appraisal guidance 230 (2011).

  • Unstable angina and NSTEMI: the early management of unstable angina and non-ST-segment-elevation myocardial infarction. NICE clinical guideline 94 (2010).

  • Prasugrel for the treatment of acute coronary syndromes with percutaneous coronary intervention. NICE technology appraisal guidance 182 (2008).

  • Drug-eluting stents for the treatment of coronary artery disease.NICE technology appraisal guidance 152 (2008).

  • MI – secondary prevention: secondary prevention in primary and secondary care for patients following a myocardial infarction. NICE clinical guideline 48 (2007).

  • National Institute for Health and Care Excellence (NICE)

  • Next